Copyright
©The Author(s) 2016.
World J Orthop. Feb 18, 2016; 7(2): 123-127
Published online Feb 18, 2016. doi: 10.5312/wjo.v7.i2.123
Published online Feb 18, 2016. doi: 10.5312/wjo.v7.i2.123
Component | Abbreviation | Value |
Age of THA patients, yr ± SD[7] | AgeH | 67.9 ± 9.0 |
Gender of THA patients, % men, % women[7] | %H-M, %H-W | 46%, 54% |
Age of RSA patient, yr ± SD | AgeS | 69.3 ± 7.7 |
Gender of reverse shoulder patients, % men, % women | %RSM, %RSW | 60%, 40% |
Standard reduction in quality of life[9] | SR | -3% |
1Pre-operative THA cost, $[7] | Hpreop | 400 |
Pre-operative RSA cost, $[2] | Rpreop | 600 |
1Cost of THA implant, $ | Himplant | 4300 |
1THA surgical and hospital costs, $ | Hsurg | 5600 |
1Total direct cost of THA, $ | dcTHA | Himplant + Hsurg = 9900 |
1Cost of post-operative implant care, $[7] | Ipostop | 1400 |
1Cost of primary THA, $ | cTHA | dcTHA + Hpreop + Ipostop = 11700 |
Cost of THA revision implant, $[13] | Hrevimplant | %cup × cCup + %liner × cLiner + %stem × cStem = 1700 |
Average cost of THA revision, $[13] | Hrev | Hsurg + Hrevimplant = 7300 |
1Cost of RSA implant, $ | Rimplant | 8900 |
1RSA surgical, hospital costs, $ | Rsurg | 6100 |
1Total direct primary RSA cost, $ | dcRSA | Rimplant + Rsurg = 15000 |
1Primary RSA cost, $ | cRSA | dcRSA + Rpreop + Ipostop = 17000 |
1RSA revision implant cost, $ | Rrevimplant | %glenoid × cGS + %Stem × cStem + %poly × cPoly %Hemi × cHemi = 4000 |
1Average revision RSA cost, $ | Rrev | Rsurg + Rrevimplant |
The length of first, second, third cycles hip, yr | hCL1, hCL2, hCL3 | 0.083, 0.416, 0.5 |
The length of first, second, third cycles shoulder, yr | sCL1, sCL2, sCL3 | 0.25, 0.25, 0.5 |
Length of cycle thereafter both, yr | CL | 1 |
Age-specific mortality rate male, female[12] | mAgeM, AgeF | 2007 United States life tables |
Mortality rate, shoulder | mS | mAgeM × %SM + mAgeF × %SF |
Mortality rate, hip | mH | mAgeM × %HM + mAgeF × %HF |
THA revision cases[13] | hRev | 44 |
Published cases[13] | hPC | 211 |
THA follow-up years[13] | hFY | 13.9 × hPC = 2932 |
Probability of THA revision/shoulder, yr | Ω1 | hRev/hFY = 0.015 |
RSA revisions[14] | sRev | 79 |
Published cases[14] | sPC | 782 |
RSA follow-up years[14] | sFY | 3.5 × sPC = 2737 |
RSA revision probability per shoulder, yr | Ω2 | sRev/sFY = 0.029 |
Utility, quality of llfe improvement, EQ-5D | pQoL, oQoL | α× PF + β× RP + γ× RE + δ× BP + ε × GH + ζ× VT + η× MH + θ × SF |
Utility hip, shoulder | qHwell, qSwell | oQOL - pQOL |
The utility associated with a THA revision, QALY | qHrev | 0.5 × qHwell |
The utility associated with a RSA revision, QALY | qSrev | 0.5 × qSwell |
- Citation: Bachman D, Nyland J, Krupp R. Reverse-total shoulder arthroplasty cost-effectiveness: A quality-adjusted life years comparison with total hip arthroplasty. World J Orthop 2016; 7(2): 123-127
- URL: https://www.wjgnet.com/2218-5836/full/v7/i2/123.htm
- DOI: https://dx.doi.org/10.5312/wjo.v7.i2.123